epitoMAP Inc., Animal Allergy Clinical Laboratories Inc. and Nippon Zenyaku Kogyo Co., Ltd. Enter into License Agreement
By asianet
epitoMAP Inc. (hereinafter "epitoMAP") and Animal Allergy Clinical Laboratories Inc. (hereinafter "AACL") entered into a License Agreement for an antibody pharmaceutical for veterinary use, CRE-DR-B, with Nippon Zenyaku Kogyo Co., Ltd. (hereinafter "ZENOAQ") on November 10, 2023. Logos: epitoMAP: https://kyodonewsprwire.jp/img/202311132696-O3-B5f8qrzL ZENOAQ: https://kyodonewsprwire.jp/img/202311132696-O5-QZ0646h5 AACL: https://kyodonewsprwire.jp/img/202311132696-O4-Hw5TKcKs Photos: https://cdn.kyodonewsprwire.jp/prwfile/release/M107929/202311132696/_prw_PI1fl_CUg5pN38.jpg https://cdn.kyodonewsprwire.jp/prwfile/release/M107929/202311132696/_prw_PI2fl_2gLRsvyi.jpg Under the terms of the Agreement, ZENOAQ will … Continued